FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2125339825> ?p ?o ?g. }

• W2125339825 endingPage "18" @default.
• W2125339825 startingPage "18" @default.
• W2125339825 abstract "<h3>Objective</h3> To evaluate the relation of topical tretinoin, a commonly used retinoid cream, with all-cause mortality in the Veterans Affairs Topical Tretinoin Chemoprevention Trial (VATTC). The planned outcome of this trial was risk of keratinocyte carcinoma, and systemic administration of certain retinoid compounds has been shown to reduce risk of this cancer but has also been associated with increased mortality risk among smokers. <h3>Design</h3> The VATTC Trial was a blinded randomized chemoprevention trial, with 2- to 6-year follow-up. Oversight was provided by multiple independent committees. <h3>Setting</h3> US Department of Veterans Affairs medical centers. <h3>Patients</h3> A total of 1131 veterans were randomized. Their mean age was 71 years. Patients with a very high estimated short-term risk of death were excluded. <h3>Interventions</h3> Application of tretinoin, 0.1%, or vehicle control cream twice daily to the face and ears. <h3>Main Outcome Measures</h3> Death, which was not contemplated as an end point in the original study design. <h3>Results</h3> The intervention was terminated 6 months early because of an excessive number of deaths in the tretinoin-treated group. Post hoc analysis of this difference revealed minor imbalances in age, comorbidity, and smoking status, all of which were important predictors of death. After adjusting for these imbalances, the difference in mortality between the randomized groups remained statistically significant. <h3>Conclusions</h3> We observed an association of topical tretinoin therapy with death, but we do not infer a causal association that current evidence suggests is unlikely. <h3>Trial Registration</h3> clinicaltrials.gov Identifier:NCT00007631" @default.
• W2125339825 created "2016-06-24" @default.
• W2125339825 creator A5003691102 @default.
• W2125339825 creator A5005003304 @default.
• W2125339825 creator A5006480686 @default.
• W2125339825 creator A5020066713 @default.
• W2125339825 creator A5024471347 @default.
• W2125339825 creator A5024802127 @default.
• W2125339825 creator A5028166007 @default.
• W2125339825 creator A5045611437 @default.
• W2125339825 creator A5061210519 @default.
• W2125339825 creator A5062808281 @default.
• W2125339825 creator A5062898568 @default.
• W2125339825 creator A5086261113 @default.
• W2125339825 creator A5089367136 @default.
• W2125339825 date "2009-01-01" @default.
• W2125339825 modified "2023-10-15" @default.
• W2125339825 title "Topical Tretinoin Therapy and All-Cause Mortality" @default.
• W2125339825 cites W127746953 @default.
• W2125339825 cites W1525444530 @default.
• W2125339825 cites W1832821854 @default.
• W2125339825 cites W1970517620 @default.
• W2125339825 cites W1973641158 @default.
• W2125339825 cites W1978145687 @default.
• W2125339825 cites W2000445173 @default.
• W2125339825 cites W2000764611 @default.
• W2125339825 cites W2021518575 @default.
• W2125339825 cites W2029135927 @default.
• W2125339825 cites W2034971632 @default.
• W2125339825 cites W2062534734 @default.
• W2125339825 cites W2064528672 @default.
• W2125339825 cites W2079760604 @default.
• W2125339825 cites W2085752173 @default.
• W2125339825 cites W2088698012 @default.
• W2125339825 cites W2103602077 @default.
• W2125339825 cites W2107212159 @default.
• W2125339825 cites W2144624499 @default.
• W2125339825 cites W2159456353 @default.
• W2125339825 cites W2167701317 @default.
• W2125339825 cites W2317242858 @default.
• W2125339825 cites W2319872820 @default.
• W2125339825 doi "https://doi.org/10.1001/archdermatol.2008.542" @default.
• W2125339825 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19153339" @default.
• W2125339825 hasPublicationYear "2009" @default.
• W2125339825 type Work @default.
• W2125339825 sameAs 2125339825 @default.
• W2125339825 citedByCount "47" @default.
• W2125339825 countsByYear W21253398252012 @default.
• W2125339825 countsByYear W21253398252013 @default.
• W2125339825 countsByYear W21253398252014 @default.
• W2125339825 countsByYear W21253398252015 @default.
• W2125339825 countsByYear W21253398252017 @default.
• W2125339825 countsByYear W21253398252018 @default.
• W2125339825 countsByYear W21253398252019 @default.
• W2125339825 countsByYear W21253398252020 @default.
• W2125339825 countsByYear W21253398252021 @default.
• W2125339825 countsByYear W21253398252022 @default.
• W2125339825 countsByYear W21253398252023 @default.
• W2125339825 crossrefType "journal-article" @default.
• W2125339825 hasAuthorship W2125339825A5003691102 @default.
• W2125339825 hasAuthorship W2125339825A5005003304 @default.
• W2125339825 hasAuthorship W2125339825A5006480686 @default.
• W2125339825 hasAuthorship W2125339825A5020066713 @default.
• W2125339825 hasAuthorship W2125339825A5024471347 @default.
• W2125339825 hasAuthorship W2125339825A5024802127 @default.
• W2125339825 hasAuthorship W2125339825A5028166007 @default.
• W2125339825 hasAuthorship W2125339825A5045611437 @default.
• W2125339825 hasAuthorship W2125339825A5061210519 @default.
• W2125339825 hasAuthorship W2125339825A5062808281 @default.
• W2125339825 hasAuthorship W2125339825A5062898568 @default.
• W2125339825 hasAuthorship W2125339825A5086261113 @default.
• W2125339825 hasAuthorship W2125339825A5089367136 @default.
• W2125339825 hasBestOaLocation W21253398251 @default.
• W2125339825 hasConcept C104317684 @default.
• W2125339825 hasConcept C126322002 @default.
• W2125339825 hasConcept C141071460 @default.
• W2125339825 hasConcept C168563851 @default.
• W2125339825 hasConcept C185592680 @default.
• W2125339825 hasConcept C187212893 @default.
• W2125339825 hasConcept C2775954498 @default.
• W2125339825 hasConcept C2775969662 @default.
• W2125339825 hasConcept C2779159551 @default.
• W2125339825 hasConcept C2781121885 @default.
• W2125339825 hasConcept C55493867 @default.
• W2125339825 hasConcept C71924100 @default.
• W2125339825 hasConceptScore W2125339825C104317684 @default.
• W2125339825 hasConceptScore W2125339825C126322002 @default.
• W2125339825 hasConceptScore W2125339825C141071460 @default.
• W2125339825 hasConceptScore W2125339825C168563851 @default.
• W2125339825 hasConceptScore W2125339825C185592680 @default.
• W2125339825 hasConceptScore W2125339825C187212893 @default.
• W2125339825 hasConceptScore W2125339825C2775954498 @default.
• W2125339825 hasConceptScore W2125339825C2775969662 @default.
• W2125339825 hasConceptScore W2125339825C2779159551 @default.
• W2125339825 hasConceptScore W2125339825C2781121885 @default.
• W2125339825 hasConceptScore W2125339825C55493867 @default.
• W2125339825 hasConceptScore W2125339825C71924100 @default.
• W2125339825 hasIssue "1" @default.

• next